These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28676440)

  • 1. Severe bone loss and multiple fractures in SCN8A-related epileptic encephalopathy.
    Rolvien T; Butscheidt S; Jeschke A; Neu A; Denecke J; Kubisch C; Meisler MH; Pueschel K; Barvencik F; Yorgan T; Oheim R; Schinke T; Amling M
    Bone; 2017 Oct; 103():136-143. PubMed ID: 28676440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early onset epileptic encephalopathy caused by de novo SCN8A mutations.
    Ohba C; Kato M; Takahashi S; Lerman-Sagie T; Lev D; Terashima H; Kubota M; Kawawaki H; Matsufuji M; Kojima Y; Tateno A; Goldberg-Stern H; Straussberg R; Marom D; Leshinsky-Silver E; Nakashima M; Nishiyama K; Tsurusaki Y; Miyake N; Tanaka F; Matsumoto N; Saitsu H
    Epilepsia; 2014 Jul; 55(7):994-1000. PubMed ID: 24888894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal hyperexcitability in a mouse model of
    Lopez-Santiago LF; Yuan Y; Wagnon JL; Hull JM; Frasier CR; O'Malley HA; Meisler MH; Isom LL
    Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2383-2388. PubMed ID: 28193882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel SCN8A mutation in a case of early-onset infantile epileptic encephalopathy: A Case Report.
    Keshri S; Goel AK; Shah S; Garg AK
    Acta Biomed; 2022 Feb; 92(S1):e2021261. PubMed ID: 35188110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early-onset movement disorder and epileptic encephalopathy due to de novo dominant SCN8A mutation.
    Singh R; Jayapal S; Goyal S; Jungbluth H; Lascelles K
    Seizure; 2015 Mar; 26():69-71. PubMed ID: 25799905
    [No Abstract]   [Full Text] [Related]  

  • 6. SCN8A mutations in Chinese patients with early onset epileptic encephalopathy and benign infantile seizures.
    Wang J; Gao H; Bao X; Zhang Q; Li J; Wei L; Wu X; Chen Y; Yu S
    BMC Med Genet; 2017 Sep; 18(1):104. PubMed ID: 28923014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel sodium channel modulator GS-458967 (GS967) is an effective treatment in a mouse model of SCN8A encephalopathy.
    Baker EM; Thompson CH; Hawkins NA; Wagnon JL; Wengert ER; Patel MK; George AL; Meisler MH; Kearney JA
    Epilepsia; 2018 Jun; 59(6):1166-1176. PubMed ID: 29782051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prax330 reduces persistent and resurgent sodium channel currents and neuronal hyperexcitability of subiculum neurons in a mouse model of SCN8A epileptic encephalopathy.
    Wengert ER; Saga AU; Panchal PS; Barker BS; Patel MK
    Neuropharmacology; 2019 Nov; 158():107699. PubMed ID: 31278928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A de novo SCN8A heterozygous mutation in a child with epileptic encephalopathy: a case report.
    Lin KM; Su G; Wang F; Zhang X; Wang Y; Ren J; Wang X; Yao Y; Zhou Y
    BMC Pediatr; 2019 Nov; 19(1):400. PubMed ID: 31672125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo SCN8A mutation identified by whole-exome sequencing in a boy with neonatal epileptic encephalopathy, multiple congenital anomalies, and movement disorders.
    Vaher U; Nõukas M; Nikopensius T; Kals M; Annilo T; Nelis M; Ounap K; Reimand T; Talvik I; Ilves P; Piirsoo A; Seppet E; Metspalu A; Talvik T
    J Child Neurol; 2014 Dec; 29(12):NP202-6. PubMed ID: 24352161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The phenotypic spectrum of SCN8A encephalopathy.
    Larsen J; Carvill GL; Gardella E; Kluger G; Schmiedel G; Barisic N; Depienne C; Brilstra E; Mang Y; Nielsen JE; Kirkpatrick M; Goudie D; Goldman R; Jähn JA; Jepsen B; Gill D; Döcker M; Biskup S; McMahon JM; Koeleman B; Harris M; Braun K; de Kovel CG; Marini C; Specchio N; Djémié T; Weckhuysen S; Tommerup N; Troncoso M; Troncoso L; Bevot A; Wolff M; Hjalgrim H; Guerrini R; Scheffer IE; Mefford HC; Møller RS;
    Neurology; 2015 Feb; 84(5):480-9. PubMed ID: 25568300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal tremor episodes and hyperekplexia-like presentation at onset in a child with SCN8A developmental and epileptic encephalopathy.
    Pons L; Lesca G; Sanlaville D; Chatron N; Labalme A; Manel V; Arzimanoglou A; de Bellescize J; Lion-François L
    Epileptic Disord; 2018 Aug; 20(4):289-294. PubMed ID: 30078772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and clinical features of SCN8A developmental and epileptic encephalopathy.
    Kim HJ; Yang D; Kim SH; Kim B; Kim HD; Lee JS; Choi JR; Lee ST; Kang HC
    Epilepsy Res; 2019 Dec; 158():106222. PubMed ID: 31675620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a human induced pluripotent stem cell line (CIPi002-A) from an early infantile epileptic encephalopathy patient with a heterozygous mutation in SCN8A.
    Zhang P; Zheng P; Ji X; Gao Y; Zhang X; Chen Q
    Stem Cell Res; 2022 Aug; 63():102862. PubMed ID: 35853415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCN8A epileptic encephalopathy mutations display a gain-of-function phenotype and divergent sensitivity to antiepileptic drugs.
    Guo QB; Zhan L; Xu HY; Gao ZB; Zheng YM
    Acta Pharmacol Sin; 2022 Dec; 43(12):3139-3148. PubMed ID: 35902765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo gain-of-function and loss-of-function mutations of SCN8A in patients with intellectual disabilities and epilepsy.
    Blanchard MG; Willemsen MH; Walker JB; Dib-Hajj SD; Waxman SG; Jongmans MC; Kleefstra T; van de Warrenburg BP; Praamstra P; Nicolai J; Yntema HG; Bindels RJ; Meisler MH; Kamsteeg EJ
    J Med Genet; 2015 May; 52(5):330-7. PubMed ID: 25725044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a de novo SCN8A mutation in a patient with epileptic encephalopathy.
    de Kovel CG; Meisler MH; Brilstra EH; van Berkestijn FM; van 't Slot R; van Lieshout S; Nijman IJ; O'Brien JE; Hammer MF; Estacion M; Waxman SG; Dib-Hajj SD; Koeleman BP
    Epilepsy Res; 2014 Nov; 108(9):1511-8. PubMed ID: 25239001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroclinical features of epileptic encephalopathy caused by SCN8A mutation.
    Takahashi S; Yamamoto S; Okayama A; Araki A; Saitsu H; Matsumoto N; Azuma H
    Pediatr Int; 2015 Aug; 57(4):758-62. PubMed ID: 25951352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SCN8A encephalopathy mutation p.Ile1327Val displays elevated sensitivity to the anticonvulsant phenytoin.
    Barker BS; Ottolini M; Wagnon JL; Hollander RM; Meisler MH; Patel MK
    Epilepsia; 2016 Sep; 57(9):1458-66. PubMed ID: 27375106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCN8A encephalopathy: Research progress and prospects.
    Meisler MH; Helman G; Hammer MF; Fureman BE; Gaillard WD; Goldin AL; Hirose S; Ishii A; Kroner BL; Lossin C; Mefford HC; Parent JM; Patel M; Schreiber J; Stewart R; Whittemore V; Wilcox K; Wagnon JL; Pearl PL; Vanderver A; Scheffer IE
    Epilepsia; 2016 Jul; 57(7):1027-35. PubMed ID: 27270488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.